Celltech Group (NYSE: CLL) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Celltech Group (NYSE: CLL)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: keokalani'nui who wrote (56)	12/4/2002 11:46:08 AM
From: nigel bates	Read Replies (1) of 123

LONDON, Dec 4 (Reuters) - Celltech Group Plc has selected a new chief executive and expects him to take over at the head of Britain's biggest biotechnology company in February, the outgoing CEO said on Wednesday. "We have identified a candidate...we believe he will join in the first couple of months of the year, probably late February," Peter Fellner told Reuters. Celltech has been looking for a new CEO since June when Fellner announced he planned to step down from the job and move up to the position of non-executive chairman. Fellner declined to say who the new man would be but market speculation has centred on Goran Ando, head of research and development at Pharmacia Corp (NYSE:PHA - News), who is expected to lose his position to his counterpart at Pfizer Inc (NYSE:PFE - News) when the two U.S. drug giants complete their merger next year.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next